Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Henry Schein 3.458, Abbott Laboratories 12.593.
Henry Schein vs Abbott Laboratories: Revenue Comparison
Henry Schein (HSIC) and Abbott Laboratories (ABT) are peers in Healthcare. Henry Schein reported revenue of $3.5B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Henry Schein's gross margin is 31.8% versus 58.0% for Abbott Laboratories. Henry Schein's net margin is 2.7% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Henry Schein, Abbott Laboratories.| Metric | Henry Schein | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.46B | $12.59B |
| Cost of Revenue | $2.36B | $5.29B |
| Gross Profit | $1.10B | $7.30B |
| Operating Income | $200.00M | $1.78B |
| Net Income | $94.00M | $928.00M |
| R&D Expense | $0 | $882.00M |
| Earnings Per Share | $0.82 | $0.53 |
| Gross Margin | 31.8% | 58.0% |
| Operating Margin | 5.8% | 14.2% |
| Net Profit Margin | 2.7% | 7.4% |
| Free Cash Flow | $196.00M | $2.89B |
| Cumulative Free Cash Flow | $9.89B | $142.48B |
| Operating Cash Flow | $242.00M | $2.49B |
| Cash & Equivalents | $157.00M | $5.10B |